Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Futura Medical, a pharmaceutical group that develops products for consumer healthcare, has filed CE mark approval for the regulatory dossier for CSD500, which is expected to be launched as a Durex-branded condom by SSL International (SSL).
Subscribe to our email newsletter
Futura Medical is expecting that the regulatory dossier for CSD500, will allow the CE mark approval process to be completed later in 2010.
Futura Medical said the submission of CE mark is a major milestone for it in the development and commercialisation of CSD500. SSL is now setting up the timing and strategy for the launch of the product.
James Barder, CEO of Futura, said: “The submission of the regulatory dossier for CSD500 is a major milestone for Futura, as the company is now on the threshold of receiving its first recurring revenues from royalty payments on product sales.
“We are close to completing our work on CSD500 as the timing and strategy for the launch of the product are under the control of SSL. However, we will continue to support SSL as appropriate as we make progress on the other opportunities within our pipeline of potential products.”